LivaNova Investor Day 2021 December 7, 2021 Intended for Investor Use Only - Not Intended for Use by Patients or Health Care Professionals Safe Harbor Certain statements in this presentation, other than purely historical information, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements include, but are not limited ...

LivaNova PLC (NASDAQ:LIVN) Q3 2021 Earnings Conference Call November 3, 2021 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Mike Matson - Needham & Company Adam Maeder - Piper Sandler Anthony Petrone - Jefferies Michael Polark - Baird Scott Bardo - Berenberg Matt Taylor - UBS Operator Good day, ladies and gentlemen and welcome to ...

Third Quarter 2021 Earnings Presentation November 3, 2021 Charlotte, VNS Therapy Patient Safe Harbor 2 Certain statements in this presentation, other than purely historical information, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements include, but are not limited to, LivaNova's plans, objectives, strategies, fi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-37599 LivaNova PLC (Exact name of registrant as specified in its ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-37599 Registrant's telephone number, including area code: (44) (0) 20 ...

LivaNova PLC (NASDAQ:LIVN) Q2 2021 Earnings Conference Call July 28, 2021 8:00 AM ET Company Participants Matthew Dodds - SVP, Corporate Development Damien McDonald - CEO Alex Shvartsburg - Interim CFO Lindsey Little - Senior Director, IR Conference Call Participants Rick Wise - Stifel Mike Matson - Needham & Company Adam Maeder - Piper Sandler Michael Polark - Baird Anthony Petrone - Jefferies Matt Taylor - UBS Scott Bardo - Berenberg Company Operator Good day, ladies and gentlemen, and welcome to LivaNova ...

alth innovation f Second Quarter 2021 Earnings Performance July 28, 2021 Starr, VNS Therapy Patient Safe Harbor 2 Certain statements in this presentation, other than purely historical information, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements include, but are not limited to, LivaNova's plans, objectives, str ...

LivaNova PLC (NASDAQ:LIVN) Q1 2021 Earnings Conference Call April 28, 2021 7:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Interim Chief Financial Officer Melissa Farina - Vice President of Investor Relations Conference Call Participants Rick Wise - Stifel Adam Maeder - Piper Sandler Anthony Petrone - Jefferies Michael Polark - Baird Scott Bardo - Berenberg Matthew Taylor - UBS Mike Matson - Needham ...

First Quarter 2021 Earnings Performance April 28, 2021 Rosario, a VNS Therapy Patient Health innovation that matters Safe Harbor 2 Certain statements in this presentation, other than purely historical information, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements include, but are not limited to, LivaNova's plans ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-37599 LivaNova PLC (Exact name of registrant as specified in its cha ...